| Market Cap | ₹2,017Cr |
| ROE | -11.28% |
| P/E Ratio(TTM) | -17.50 |
| EPS(TTM) | -12.50 |
| P/B Ratio | 2.06 |
| Dividend Yield | 0.09% |
| Industry P/E | 32.56 |
| Book Value | 106.21 |
| Debt to Equity | 1.02 |
| Face Value | 2 |
| Parent Organisation | Indoco Remedies Limited |
| Managing Director | MS. ADITI PANANDIKAR |
| Founded | 1947 |
| NSE Symbol | INDOCO |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 41.46 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 36.06 | ||
| Wockhardt | NA (0.00%) | -455.16 | ||
| Cohance Lifesciences | NA (0.00%) | 51.97 |